Literature DB >> 1902158

Cytokine content in pleural effusion. Comparison between tuberculous and carcinomatous pleurisy.

K Shimokata1, H Saka, T Murate, Y Hasegawa, T Hasegawa.   

Abstract

Tuberculous pleurisy is a good model for resolution of local cellular immunity. It would be expected that tuberculous pleural fluid contains a variety of immunologically important cytokines because of the accumulation of immunocompetent cells in the pleural cavity. We studied interleukin 1 (IL-1), interleukin 2 (IL-2), and interferon gamma (IFN-gamma) levels in pleural fluid of 20 patients with tuberculous pleurisy and compared them with those in pleural fluid of 20 patients with malignant pleurisy. We also evaluated adenosine deaminase (ADA) levels in both effusions. Tuberculous pleural fluid had higher levels of IL-1, IL-2, IFN-gamma, and ADA than malignant pleural fluid. Although the difference of IL-1 level between tuberculous and malignant pleural fluid was modest, that of IL-2, IFN-gamma, and ADA was dominant. These findings suggest that activated T lymphocytes in tuberculous pleural fluid concern the production of lymphokines at the morbid site and they effectively exert local cellular immunity through the action of such lymphokines.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902158     DOI: 10.1378/chest.99.5.1103

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

1.  Comparative evaluation of cytokines, T-cell apoptosis, and costimulatory molecule expression in tuberculous and nontuberculous pleurisy.

Authors:  Priya Rajavelu; Supriya Pokkali; Umashankar P; Kamlesh Bhatt; P R Narayanan; Padmini Salgame; Sulochana D Das
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

2.  Kinetics of purified protein derivative (PPD) proliferation reflects underlying suppressor mechanisms revealed by limiting dilution analysis (LDA) in patients with extrapulmonary tuberculosis (TB).

Authors:  P T Lukey; S E Latouf; S R Ress
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

3.  Prognostic value of CD4+ lymphocytes in pleural cavity of patients with non-small cell lung cancer.

Authors:  K Takahashi; S Saito; Y Kamamura; M Katakawa; Y Monden
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

Review 4.  Tuberculous pleurisy and adenosine deaminase.

Authors:  G H Bothamley
Journal:  Thorax       Date:  1995-06       Impact factor: 9.139

Review 5.  Diagnostic tests in pleural effusion--an update.

Authors:  N Berkman; M R Kramer
Journal:  Postgrad Med J       Date:  1993-01       Impact factor: 2.401

6.  The role of T cells in rheumatoid arthritis.

Authors:  G S Firestein; N J Zvaifler
Journal:  Ann Rheum Dis       Date:  1993-10       Impact factor: 19.103

7.  Interferon gamma for diagnosing tuberculous pleural effusions.

Authors:  S Wongtim; U Silachamroon; K Ruxrungtham; V Udompanich; S Limthongkul; P Charoenlap; C Nuchprayoon
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

8.  Inhibition of rat pleural mesothelial cell nitric oxide synthesis by transforming growth factor-beta 1.

Authors:  M W Owens; S A Milligan; M B Grisham
Journal:  Inflammation       Date:  1996-12       Impact factor: 4.092

9.  Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis.

Authors:  M J Fenton; M W Vermeulen; S Kim; M Burdick; R M Strieter; H Kornfeld
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

10.  Serum amyloid alpha in parapneumonic effusions.

Authors:  Vagelis Boultadakis; Vasilis Skouras; Demosthenes Makris; Aggeliki Damianaki; Dimitrios J Nikoulis; Theodoros Kiropoulos; Smaragda Oikonomidi; Irene Tsilioni; Konstantinos Gourgoulianis
Journal:  Mediators Inflamm       Date:  2011-08-25       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.